Companies / Ligand Pharmaceuticals Inc / Activity
Activity — Ligand Pharmaceuticals Inc
110 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jun 5, 2026 | Lamattina John L Director | Grant | Non-Qualified Stock Option (right to buy) | — | +3K | 2,938 0.01% of shares | low |
| Mar 4, 2026 | Reardon Andrew Executive | Exercise | Employee Stock Option (right to buy) | — | -5K -8.41% | 54,444 0.27% of shares | low |
| Mar 11, 2026 | Espinoza Octavio Executive | Exercise | Employee Stock Option (right to buy) | — | -2K -100.00% | 0 0.00% of shares | low |
| Mar 4, 2026 | Espinoza Octavio Executive | Exercise | Employee Stock Option (right to buy) | — | -466 -100.00% | 0 0.00% of shares | low |
| Mar 4, 2026 | Espinoza Octavio Executive | Exercise | Employee Stock Option (right to buy) | — | -2K -100.00% | 0 0.00% of shares | low |
| Mar 2, 2026 | Espinoza Octavio Executive | Grant | Employee Stock Option (right to buy) | — | +24K | 23,527 0.12% of shares | low |
| Mar 2, 2026 | Davis Todd C CEO | Grant | Employee Stock Option (right to buy) | — | +50K | 50,058 0.25% of shares | low |
| Mar 2, 2026 | Reardon Andrew Executive | Grant | Employee Stock Option (right to buy) | — | +22K | 21,525 0.11% of shares | low |
| Mar 3, 2026 | Sabba Stephen L Director | Exercise | Non- Qualified Stock Option (right to buy) | — | -2K -100.00% | 0 0.00% of shares | low |
| Mar 6, 2026 | Lamattina John L Director | Exercise | Non-Qualified Stock Option (right to buy) | — | -2K -100.00% | 0 0.00% of shares | low |